Literature DB >> 26207517

Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents.

Maya P Lipert1, Naír Rodríguez-Hornedo1.   

Abstract

In this manuscript we bring together concepts that are relevant to the solubilization and thermodynamic stability of cocrystals in the presence of drug solubilizing agents. Simple equations are derived that allow calculation of cocrystal solubilization and transition point solubility. Analysis of 10 cocrystals in 6 different solubilizing agents shows that cocrystal solubilization is quantitatively predicted from drug solubilization. Drug solubilizing agents such as surfactants and lipid-based media are also shown to induce cocrystal transition points, where drug and cocrystal solubilities are equal, and above which the cocrystal solubility advantage over drug is eliminated. We have discovered that cocrystal solubility at the transition point (S*) is independent of solubilizing agent, and can be predicted from knowledge of only the aqueous solubilities of drug and cocrystal. For 1:1 cocrystals, S* = (Scocrystal,aq)(2)/Sdrug,aq. S* is a key indicator of cocrystal thermodynamic stability and establishes the upper solubility limit below which cocrystal is more soluble than the constituent drug. These findings have important implications to tailor cocrystal solubility and stability in pharmaceutical formulations from commonly available drug solubility descriptors.

Entities:  

Keywords:  biorelevant media; co-crystal; cocrystal; enhancing solubility; formulation; lipids; micelles; solubilization; solubilizing agent; stability; surfactant; transition point

Mesh:

Substances:

Year:  2015        PMID: 26207517      PMCID: PMC5109980          DOI: 10.1021/acs.molpharmaceut.5b00111

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  12 in total

1.  Bioavailability of indomethacin-saccharin cocrystals.

Authors:  Min-Sook Jung; Jeong-Soo Kim; Min-Soo Kim; Amjad Alhalaweh; Wonkyung Cho; Sung-Joo Hwang; Sitaram P Velaga
Journal:  J Pharm Pharmacol       Date:  2010-11       Impact factor: 3.765

2.  Reaction crystallization of pharmaceutical molecular complexes.

Authors:  Naír Rodríguez-Hornedo; Sarah J Nehm; Kurt F Seefeldt; Yomaira Pagan-Torres; Christopher J Falkiewicz
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

3.  Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.

Authors:  Miranda L Cheney; David R Weyna; Ning Shan; Mazen Hanna; Lukasz Wojtas; Michael J Zaworotko
Journal:  J Pharm Sci       Date:  2010-12-22       Impact factor: 3.534

Review 4.  Pharmaceutical cocrystals and poorly soluble drugs.

Authors:  Ranjit Thakuria; Amit Delori; William Jones; Maya P Lipert; Lilly Roy; Naír Rodríguez-Hornedo
Journal:  Int J Pharm       Date:  2012-12-01       Impact factor: 5.875

5.  Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.

Authors:  Daniel P McNamara; Scott L Childs; Jennifer Giordano; Anthony Iarriccio; James Cassidy; Manjunath S Shet; Richard Mannion; Ed O'Donnell; Aeri Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Cocrystals of quercetin with improved solubility and oral bioavailability.

Authors:  Adam J Smith; Padmini Kavuru; Lukasz Wojtas; Michael J Zaworotko; R Douglas Shytle
Journal:  Mol Pharm       Date:  2011-08-25       Impact factor: 4.939

7.  Performance comparison of a co-crystal of carbamazepine with marketed product.

Authors:  Magali B Hickey; Matthew L Peterson; Lisa A Scoppettuolo; Sherry L Morrisette; Anna Vetter; Hector Guzmán; Julius F Remenar; Zhong Zhang; Mark D Tawa; Sean Haley; Michael J Zaworotko; Orn Almarsson
Journal:  Eur J Pharm Biopharm       Date:  2006-12-28       Impact factor: 5.571

8.  The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics.

Authors:  Annette Bak; Anu Gore; Evelyn Yanez; Mary Stanton; Sunita Tufekcic; Rashid Syed; Anna Akrami; Mark Rose; Sekhar Surapaneni; Tracy Bostick; Anthony King; Sesha Neervannan; Drazen Ostovic; Arun Koparkar
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

9.  Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs.

Authors:  E Galia; E Nicolaides; D Hörter; R Löbenberg; C Reppas; J B Dressman
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

10.  pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.

Authors:  Amjad Alhalaweh; Lilly Roy; Naír Rodríguez-Hornedo; Sitaram P Velaga
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

View more
  8 in total

1.  Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.

Authors:  Yitian M Chen; Naír Rodríguez-Hornedo
Journal:  Cryst Growth Des       Date:  2018-02-14       Impact factor: 4.076

Review 2.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

3.  Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.

Authors:  Maya P Lipert; Lilly Roy; Scott L Childs; Naír Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2015-09-21       Impact factor: 3.534

Review 4.  Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.

Authors:  Gislaine Kuminek; Fengjuan Cao; Alanny Bahia de Oliveira da Rocha; Simone Gonçalves Cardoso; Naír Rodríguez-Hornedo
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

5.  Mechanistic Basis of Cocrystal Dissolution Advantage.

Authors:  Fengjuan Cao; Gordon L Amidon; Naír Rodríguez-Hornedo; Gregory E Amidon
Journal:  J Pharm Sci       Date:  2017-10-06       Impact factor: 3.534

6.  How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability.

Authors:  G Kuminek; N Rodríguez-Hornedo; S Siedler; H V A Rocha; S L Cuffini; S G Cardoso
Journal:  Chem Commun (Camb)       Date:  2016-04-04       Impact factor: 6.222

7.  Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.

Authors:  Hakyeong Kim; Soeun Jang; Il Won Kim
Journal:  Pharmaceutics       Date:  2021-04-25       Impact factor: 6.321

8.  Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs.

Authors:  Zun Huang; Sven Staufenbiel; Roland Bodmeier
Journal:  Pharm Res       Date:  2022-05-12       Impact factor: 4.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.